Table 3 Demographic data of group C (3–6 years, n = 141)
From: The efficacy and safety of mivacurium in pediatric patients
Subgroups | n | Percentage in group A (%) | Sex (M/F) | Body weight (kg) | Induction dose (mg/kg) | Injecting time (s) |
|---|---|---|---|---|---|---|
Group 9 | 34 | 24 | 22/12 | 20.3 ± 5.2 | 0.20 | 20 |
Group 10 | 36 | 26 | 23/13 | 19.1 ± 5.9 | 0.20 | 40 |
Group 11 | 35 | 24 | 23/12 | 19.8 ± 6.5 | 0.25 | 20 |
Group 12 | 36 | 26 | 24/12 | 17.9 ± 5.5 | 0.25 | 40 |